MONGOLIA COVID-19 EMERGENCY RESPONSE AND HEALTH SYSTEM PREPAREDNESS PROJECT

Abstract*

The development objective of the COVID-19 (Coronavirus) Emergency Response and Health System Preparedness Project for Mongolia is to strengthen Mongolia’s capacity to prevent and respond to the COVID-19 outbreak and strengthen national systems for public health preparedness. The project comprises of four components. The first component, emergency COVID-19 prevention and response aim to slow down and limit the spread of COVID-19 in the country and... Show More

Development Objective

The proposed project development objective is to strengthen Mongolia’s capacity to prevent and respond to the COVID-19 outbreak and strengthen national systems for public health preparedness.

Key Details

Project Details

Project ID
P173799
Status
Closed
Team Leader
Fang Yang , Pagma Genden
Borrower 2
Mongolia

Country
Mongolia
Disclosure Date
April 1, 2020
Approval Date
(as of board presentation)
April 2, 2020
Effective Date
April 24, 2020

Total Project Cost 1
US$ 77.60 million
Implementing Agency
Ministry of Health
Region
East Asia and Pacific
Fiscal Year 3
2020

Commitment Amount
US$ 77.60 million
Environmental Category
N/A
Environmental and Social Risk
Substantial
Closing Date
February 28, 2025

Consultant Services required
No
Last Stage Reached
BANK APPROVED
Last Update Date
May 1, 2024

Associated Projects
P175730

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control100%
- FY17 - Pandemic Response100%
FY17 - Health Systems and Policies51%
- FY17 - Health System Strengthening51%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
International Bank for Reconstruction and Development	13.80
IDA Credit	63.80

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	13.80
IDA Commitment	63.80
IBRD + IDA Commitment	77.60

Lending Instrument
Grant Amount	N/A
Total Project Cost**	77.60

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

No data available.

Detailed Financial Activity as of March 31, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Oct 15, 2021	IBRD-90820	Int Charges	1,395.67
Oct 15, 2021	IBRD-90820	Int Charges	65,169.23
May 14, 2021	IBRD-90820	Loan Disb	147,782.40
Jun 23, 2021	IBRD-90820	Loan Disb	379,526.00
May 28, 2021	IBRD-90820	Loan Disb	131,384.00
Apr 15, 2021	IBRD-90820	Int Charges	2,667.97
Apr 15, 2021	IBRD-90820	Int Charges	25,730.17
Sep 1, 2021	IBRD-90820	Loan Disb	197,076.00
Sep 28, 2021	IBRD-90820	Loan Disb	569,289.00
Apr 15, 2022	IBRD-90820	Int Charges	460.48
Apr 15, 2022	IBRD-90820	Int Charges	785.54
Apr 15, 2022	IBRD-90820	Int Charges	72,573.15
Jul 12, 2021	IDA-65940	Loan Disb	2,057,664.00
Jul 16, 2021	IDA-65940	Loan Disb	239,254.98
Jul 8, 2021	IDA-68330	Loan Disb	2,000,000.00
Nov 1, 2021	IDA-65940	Loan Disb	723,975.25
Apr 15, 2022	IDA-65940	Int Charges	65,363.67
Apr 15, 2022	IDA-68330	Int Charges	120,558.02
Apr 15, 2022	IDA-68330	Int Charges	72,270.70
Apr 15, 2022	IDA-68330	Int Charges	72,270.70
Apr 15, 2022	IDA-68330	Int Charges	64.13
Apr 15, 2022	IDA-68330	Int Charges	64.13
Apr 15, 2022	IDA-65940	Int Charges	38,695.79
Apr 15, 2022	IDA-65940	Int Charges	38,695.79
Apr 15, 2022	IDA-65940	Int Charges	522.42
Apr 15, 2022	IDA-65940	Int Charges	522.42
Apr 15, 2023	IDA-65940	Int Charges	47,620.21
Apr 15, 2023	IDA-65940	Int Charges	79,310.04
Apr 15, 2023	IDA-65940	Int Charges	953.22
Apr 15, 2023	IDA-65940	Int Charges	953.22
Apr 15, 2023	IDA-68330	Int Charges	228,583.73
Apr 15, 2023	IDA-68330	Int Charges	129,814.95
Dec 19, 2022	IDA-68330	Loan Disb	9,000,000.00
Dec 30, 2021	IDA-68330	Loan Disb	30,500,000.00
Oct 15, 2022	IDA-68330	Int Charges	185,067.80
Oct 15, 2022	IDA-65940	Int Charges	2,635.99
Oct 15, 2022	IDA-65940	Int Charges	2,635.99
Oct 15, 2022	IDA-65940	Int Charges	35,130.05
Oct 15, 2022	IDA-65940	Int Charges	62,943.39
Oct 15, 2022	IDA-68330	Int Charges	4,861.86
Oct 15, 2022	IDA-68330	Int Charges	4,861.86
Oct 15, 2022	IDA-68330	Int Charges	106,178.84
Oct 15, 2022	IDA-68330	Int Charges	106,178.84
Oct 15, 2022	IDA-65940	Int Charges	35,130.05
Nov 21, 2022	IDA-65940	Loan Disb	-61,550.84
Feb 11, 2021	IBRD-90820	Loan Disb	4,805,097.50
Feb 11, 2021	IBRD-90820	Loan Disb	305,200.00
Dec 21, 2020	IBRD-90820	Loan Disb	25,035.50
Mar 24, 2021	IBRD-90820	Loan Disb	18,900.00
Feb 23, 2021	IBRD-90820	Loan Disb	434,253.40
Mar 22, 2021	IBRD-90820	Loan Disb	130,800.00
Jul 16, 2021	IBRD-90820	Loan Disb	836,153.44
Oct 15, 2021	IBRD-90820	Int Charges	839.56
May 27, 2021	IBRD-90820	Loan Disb	416,073.06
Jun 11, 2021	IBRD-90820	Loan Disb	1,500,000.00
Apr 8, 2021	IBRD-90820	Loan Disb	82,836.76
Apr 15, 2021	IBRD-90820	Loan Disb	98,521.60
May 14, 2021	IBRD-90820	Loan Disb	178,563.00
Dec 22, 2020	IBRD-90820	Loan Disb	75,106.50
Apr 2, 2020	IDA-65940	Loan Commitment	13,100,000.00
Apr 2, 2020	IBRD-90820	Loan Commitment	13,800,000.00
Feb 11, 2021	IDA-68330	Loan Commitment	50,700,000.00
Oct 15, 2020	IDA-65940	Int Charges	5,744.65
Oct 15, 2020	IDA-65940	Int Charges	5,744.65
Oct 15, 2020	IDA-65940	Int Charges	9,554.41
Jun 30, 2021	IDA-65940	Loan Disb	525,436.75
Apr 15, 2021	IDA-65940	Int Charges	15,516.87
Apr 15, 2021	IDA-65940	Int Charges	25,273.53
Apr 22, 2021	IDA-65940	Loan Disb	410,702.00
Mar 26, 2021	IDA-65940	Loan Disb	852,870.00
Mar 31, 2021	IDA-65940	Loan Disb	31,416.00
Apr 28, 2021	IDA-65940	Loan Disb	2,000,470.50
Apr 28, 2021	IDA-65940	Loan Disb	47,124.00
May 27, 2021	IDA-65940	Loan Disb	54,981.35
Oct 15, 2021	IDA-65940	Int Charges	32,437.67
Oct 15, 2021	IDA-65940	Int Charges	32,437.67
Oct 15, 2021	IDA-65940	Int Charges	54,062.78
Apr 15, 2021	IDA-65940	Int Charges	20.21
Apr 15, 2021	IDA-65940	Int Charges	15,516.87
Oct 15, 2021	IDA-68330	Int Charges	4,008.19
Oct 15, 2021	IDA-65940	Int Charges	580.99
Oct 15, 2021	IDA-68330	Int Charges	4,008.19
Oct 15, 2021	IDA-68330	Int Charges	6,680.27
Aug 6, 2020	IDA-65940	Loan Disb	2,000,000.00
Aug 6, 2020	IDA-65940	Loan Disb	2,000,000.00
Jan 10, 2024	IDA-68330	Loan Disb	4,560,696.00
Oct 15, 2023	IDA-68330	Int Charges	4,586.63
Oct 15, 2023	IDA-68330	Int Charges	147,203.78
Oct 15, 2023	IDA-68330	Int Charges	147,203.78
Oct 15, 2023	IDA-65940	Int Charges	1,591.40
Oct 15, 2023	IDA-65940	Int Charges	46,925.26
Oct 15, 2023	IDA-65940	Int Charges	46,925.26
Oct 15, 2023	IDA-68330	Int Charges	245,339.62
Sep 27, 2022	IDA-65940	Loan Disb	2,417,285.50
Apr 15, 2023	IDA-68330	Int Charges	10,181.11
Apr 15, 2023	IDA-68330	Int Charges	10,181.11
Apr 15, 2023	IDA-68330	Int Charges	129,814.95
Apr 15, 2023	IDA-65940	Int Charges	47,620.21
Jul 7, 2022	IBRD-90820	Loan Disb	630,154.20
Apr 15, 2022	IBRD-90820	Int Charges	125.68
Aug 14, 2020	IBRD-90820	Loan Disb	500,000.00
Apr 24, 2020	IBRD-90820	Loan Disb	34,500.00
Apr 24, 2020	IBRD-90820	Fee Charges	34,500.00
Sep 23, 2020	IBRD-90820	Loan Disb	2,059,327.50
Oct 15, 2020	IBRD-90820	Int Charges	2,179.06
Apr 15, 2024	IDA-65940	Int Charges	44,986.38
Apr 15, 2024	IDA-65940	Int Charges	44,986.38
Apr 15, 2024	IDA-65940	Int Charges	78,593.84
Apr 15, 2024	IDA-68330	Int Charges	6,800.14
Apr 15, 2024	IDA-68330	Int Charges	6,800.14
Apr 15, 2024	IDA-68330	Int Charges	150,021.84
Apr 15, 2024	IDA-68330	Int Charges	150,021.84
Apr 15, 2024	IDA-68330	Int Charges	261,369.94
Apr 15, 2024	IDA-65940	Int Charges	2,169.94
Apr 15, 2024	IDA-65940	Int Charges	2,169.94
Oct 15, 2023	IDA-65940	Int Charges	78,208.75
Apr 15, 2024	IBRD-90820	Int Charges	4,786.56
Apr 15, 2024	IBRD-90820	Int Charges	469,650.62
Oct 15, 2022	IBRD-90820	Int Charges	358.24
Oct 15, 2022	IBRD-90820	Int Charges	200,543.94
Apr 15, 2023	IBRD-90820	Int Charges	354,861.40
Apr 15, 2023	IBRD-90820	Int Charges	14,108.75
Oct 15, 2023	IBRD-90820	Int Charges	7,283.63
Oct 15, 2023	IBRD-90820	Int Charges	433,372.38
May 20, 2021	IBRD-90820	Loan Disb	244,420.20

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Overall Implementation Progress (IP)	Satisfactory	2025-02-27
Procurement	Satisfactory	2025-02-27
Project Management	Satisfactory	2025-02-27
Progress towards achievement of PDO	Satisfactory	2025-02-27
Monitoring and Evaluation	Moderately Satisfactory	2025-02-27
Financial Management	Satisfactory	2025-02-27

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Number of hospitals meeting MOH established standards to manage Severe Acute Respiratory Infections (SARI) patients including intensive care	Value	0.00	49.00	24.00
	Date	March 18, 2020	April 20, 2024	September 30, 2024
	Comment

Number of hospitals with increased diagnostic capacity, including but not limited to laboratories and COVID-19 virus Value 0.00 35.00 59.00
Date August 2, 2022 April 20, 2024 September 30, 2024
Comment
Percentage of the total population that has received a full primary course (two doses) Value 66.00 66.90 70.00
Date August 2, 2022 April 20, 2024 September 30, 2024
Comment
Share of females Value 50.30 51.02 50.00
Date August 2, 2022 April 20, 2024 September 30, 2024
Comment
Difference between Ulaanbaatar and Aimags (Percentage) Value 9.70 8.50 7.00
Date August 2, 2022 April 20, 2024 September 30, 2024
Comment
Percentage of total population that has received a first booster (third dose) Value 32.00 32.00 50.00
Date August 2, 2022 April 20, 2024 September 30, 2024
Comment
Share of females Value 51.00 51.00 50.00
Date August 2, 2022 April 20, 2024 September 30, 2024
Comment
Difference between Ulaanbaatar and Aimags (Percentage) Value 4.40 4.40 2.00
Date August 2, 2022 April 20, 2024 September 30, 2024
Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Number of mass media messages on COVID-19 vaccination targeted at hard-to-reach populations, including rural areas, minority groupsand high risk groups	Value	0.00	12.00	20.00
	Date	March 18, 2020	April 20, 2024	September 30, 2024
	Comment

Number of soum health centers with improved emergency transportation Value 0.00 18.00 20.00
Date February 1, 2023 April 20, 2024 August 30, 2024
Comment
Independent review of equipment purchase and utilization carried out annually Value NA No Yes
Date March 18, 2020 April 20, 2024 September 30, 2024
Comment
Number of ventilators provided to hospitals Value 0.00 215.00 200.00
Date March 18, 2020 April 20, 2024 September 30, 2024
Comment
Six monthly reports prepared and circulated in a timely manner Value No Yes Yes
Date March 31, 2020 April 20, 2024 September 30, 2024
Comment

Number of “One Health”-based simulation exercises conducted and certified by Ministry of Health/ Agriculture at national and sub-national levels	Value	0.00	4.00	3.00
	Date	March 18, 2020	April 20, 2024	September 30, 2024
	Comment

Beneficiary feedback and response mechanisms on COVID-19 prevention and vaccination established and carried out with reporting on every six months	Value	No	Yes	Yes
	Date	November 10, 2020	April 20, 2024	September 30, 2024
	Comment

Number of health staff trained in infection prevention and control, medical waste management, field epidemiology, and adverse effects of vaccination	Value	0.00	2100.00	1000.00
	Date	August 2, 2022	April 20, 2024	September 30, 2024
	Comment

Share of vaccination units fully equipped with functioning cold chain Value 0.00 100.00 95.00
Date November 10, 2020 April 20, 2024 September 30, 2024
Comment
Share of targeted staff in Ulaanbaatar versus Aimags that have received the training Value 0.00 80.00 0.00
Date
Comment

Percentage of the total population that has received a full primary course (two doses)	Value	66.00	66.90	70.00
	Date	August 2, 2022	April 20, 2024	September 30, 2024
	Comment

Share of females	Value	50.30	51.02	50.00
	Date	August 2, 2022	April 20, 2024	September 30, 2024
	Comment

Difference between Ulaanbaatar and Aimags (Percentage)	Value	9.70	8.50	7.00
	Date	August 2, 2022	April 20, 2024	September 30, 2024
	Comment

Percentage of total population that has received a first booster (third dose)	Value	32.00	32.00	50.00
	Date	August 2, 2022	April 20, 2024	September 30, 2024
	Comment

Share of females	Value	51.00	51.00	50.00
	Date	August 2, 2022	April 20, 2024	September 30, 2024
	Comment

Difference between Ulaanbaatar and Aimags (Percentage)	Value	4.40	4.40	2.00
	Date	August 2, 2022	April 20, 2024	September 30, 2024
	Comment

MONGOLIA COVID-19 EMERGENCY RESPONSE AND HEALTH SYSTEM PREPAREDNESS PROJECT

Abstract*

Development Objective

Key Details

Project Details

Sectors

Themes

Stay Connected, sign up for our:

Project Map

Finances

Financing Plan (US$ Millions)

Total Project Financing (US$ Millions)

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Detailed Financial Activity as of March 31, 2025

Ratings

IMPLEMENTATION RATINGS

COMPLETION RATINGS

INDEPENDENT EVALUATION RATINGS

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INTERMEDIATE RESULTS INDICATORS